PharmaCyte Biotech, Inc.
$0.34
-0.02 (-4.81%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -19.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -38.3%
Own PMCB?
See how PMCB contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.